Skip to main content

Animations

MJFF Publications

5391 - 5400 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2021
  • 2021
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: The ADORA1 mutation linked to early-onset Parkinson’s disease alters adenosine A1-A2A receptor heteromer formation and function
    Journal Name: Biomedicine & Pharmacotherapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.biopha.2022.113896
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s disease
    Journal Name: Biomedicine & Pharmacotherapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.biopha.2022.113908
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Special Issue on new therapeutic approaches to Parkinson disease
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.108998
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109213
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Preserved motor memory in Parkinson's disease
    Journal Name: Neuropsychologia
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108161
    Citation Count: 13
  • Summary Details
    RESTRICTED
    Title: Quantitative Cellular Changes in the Thalamus of Patients with Multiple System Atrophy
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.02.003
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Motor Thalamic Deep Brain Stimulation Alters Cortical Activity and Shows Therapeutic Utility for Treatment of Parkinson’s Disease Symptoms in a Rat Model
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.02.019
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: Co-registration of Imaging Modalities (MRI, CT and PET) to Perform Frameless Stereotaxic Robotic Injections in the Common Marmoset
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.11.009
    Citation Count: 9
  • Summary Details
    RESTRICTED
    Title: Functional Interaction Between α-Synuclein and Nurr1 in Dopaminergic Neurons
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2022.10.011
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Une valine 11 codée par le gène HLA-DRB1 est associée inversement au risque de maladie de Parkinson et interagit avec l’initiation du tabagisme
    Journal Name: Revue Neurologique
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurol.2022.02.151
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.